Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection.
Department of Clinical Sciences, The Institute of Liver Studies, Guy's, King's and St Thomas' School of Medicine, King's College Hospital, London, UK.
J
J
Li
L
L
Collins
X
X
Zhang
K
K
Gustafsson
J W
JW
Fabre
D000818:Animals; D002908:Chronic Disease; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000008:administration & dosage*; D006084:Graft Rejection / Q000628:therapy*; D006801:Humans; D016023:Integrins / Q000235:genetics*; D008565:Membrane Proteins / Q000235:genetics*; D009131:Muscle, Smooth, Vascular; D010455:Peptides / Q000008:administration & dosage*; D014184:Transplantation, Homologous
D016023:Integrins; D008565:Membrane Proteins; D010455:Peptides